Nearly a dozen members of Congress are urging the US Army not to issue an exclusive license to Sanofi (SNY) Pasteur to develop a vaccine for the Zika virus over concerns the product may be priced too high for many Americans, even though it was developed with taxpayer funds.

“In order to ensure that the investment made by taxpayers was worthwhile, it is critical that we ensure the vaccine to prevent against the Zika virus is accessible to anyone who requires it,” the lawmakers wrote on Wednesday in a letter to Robert Speer, the Acting Secretary of the Army.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy